scholarly article | Q13442814 |
P2093 | author name string | H Tanaka | |
M Nakai | |||
T Goto | |||
S Omura | |||
S Hinata | |||
Y Morikawa | |||
H Tomoda | |||
C Aizawa | |||
P2860 | cites work | Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp | Q69663649 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2868-73 | |
P577 | publication date | 1996-02-02 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding | |
P478 | volume | 271 |
Q33785367 | A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner |
Q35826475 | A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles |
Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
Q39531429 | A time-of-drug addition approach to target identification of antiviral compounds |
Q46463465 | Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor |
Q24303633 | BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1 |
Q41284460 | Bioorthogonal mimetics of palmitoyl-CoA and myristoyl-CoA and their subsequent isolation by click chemistry and characterization by mass spectrometry reveal novel acylated host-proteins modified by HIV-1 infection |
Q34065642 | Budding of enveloped viruses from the plasma membrane. |
Q45512144 | Comparing capsid assembly of primate lentiviruses and hepatitis B virus using cell-free systems |
Q36325523 | Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy |
Q42688106 | Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag. |
Q40776235 | Down-regulation of N-myristoyl transferase expression in human T-cell line CEM by human immunodeficiency virus type-1 infection |
Q44448449 | Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins |
Q33815436 | Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes. |
Q34030593 | HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae |
Q40883661 | Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies |
Q33785351 | Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue |
Q40928746 | In vitro assembly of human immunodeficiency virus type 1 Gag protein |
Q39879873 | In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles |
Q33653475 | In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. |
Q36942505 | Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol |
Q37633410 | Interrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association |
Q30477939 | Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells |
Q35113734 | Molecular determinants that regulate plasma membrane association of HIV-1 Gag |
Q40011798 | Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association |
Q41380626 | Myristoylation |
Q37568060 | Myristoylation of the RING finger Z protein is essential for arenavirus budding |
Q35635000 | Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells |
Q33642818 | Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. |
Q34978433 | Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding |
Q34781698 | Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. |
Q39683238 | Role of RNA in facilitating Gag/Gag-Pol interaction |
Q38228643 | Role of the nucleocapsid region in HIV-1 Gag assembly as investigated by quantitative fluorescence-based microscopy |
Q33794223 | Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly |
Q36485425 | Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms |
Q40175971 | Synchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring. |
Q37928913 | Targeting human immunodeficiency virus type 1 assembly, maturation and budding. |
Q36824510 | The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress |
Q21131598 | The interferon response inhibits HIV particle production by induction of TRIM22 |
Search more.